Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247997196> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W4247997196 endingPage "83" @default.
- W4247997196 startingPage "79" @default.
- W4247997196 abstract "Bioequivalence of rusovastatin in healthy human volunteers was done using saliva and plasma matrices in order to investigate the robustness of using saliva instead of plasma as a surrogate for bioequivalence of class III drugs according to the salivary excretion classification system (SECS). Saliva and plasma samples were collected for 72 h after oral administration of rusovastatin 40 mg to 12 healthy humans. Saliva and plasma pharmacokinetic parameters were calculated by non-compartmental analysis. Analysis of variance, 90 % confidence intervals, and intra-subject and inter-subject variability values of pharmacokinetic parameters were calculated using Kinetica program V5. Human effective intestinal permeability was also calculated by SimCYP program V13. Rusovastatin falls into class III (high permeability/low fraction unbound to plasma proteins) and hence was subjected to salivary excretion. A correlation coefficient of 0.99 between saliva and plasma concentrations, and a saliva/plasma concentration ratio of 0.175 were observed. The 90 % confidence limits of area under the curve (AUClast) and maximum concentration (C max) showed similar trends in both saliva and plasma. On the other hand, inter- and intra-subject variability values in saliva were higher than in plasma, leading to the need for a slightly higher number of subjects to be used in saliva studies. Non-invasive saliva sampling instead of the invasive plasma sampling method can be used as a surrogate for bioequivalence of SECS class III drugs when an adequate sample size is used." @default.
- W4247997196 created "2022-05-12" @default.
- W4247997196 creator A5005031221 @default.
- W4247997196 creator A5033752774 @default.
- W4247997196 date "2015-02-11" @default.
- W4247997196 modified "2023-10-16" @default.
- W4247997196 title "Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System" @default.
- W4247997196 cites W1498305210 @default.
- W4247997196 cites W2006967678 @default.
- W4247997196 cites W2084052997 @default.
- W4247997196 cites W2095335567 @default.
- W4247997196 cites W21351818 @default.
- W4247997196 doi "https://doi.org/10.1007/s40268-015-0080-1" @default.
- W4247997196 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25666686" @default.
- W4247997196 hasPublicationYear "2015" @default.
- W4247997196 type Work @default.
- W4247997196 citedByCount "3" @default.
- W4247997196 countsByYear W42479971962017 @default.
- W4247997196 countsByYear W42479971962020 @default.
- W4247997196 countsByYear W42479971962022 @default.
- W4247997196 crossrefType "journal-article" @default.
- W4247997196 hasAuthorship W4247997196A5005031221 @default.
- W4247997196 hasAuthorship W4247997196A5033752774 @default.
- W4247997196 hasBestOaLocation W42479971961 @default.
- W4247997196 hasConcept C10146269 @default.
- W4247997196 hasConcept C112705442 @default.
- W4247997196 hasConcept C126322002 @default.
- W4247997196 hasConcept C185592680 @default.
- W4247997196 hasConcept C42404028 @default.
- W4247997196 hasConcept C43617362 @default.
- W4247997196 hasConcept C44249647 @default.
- W4247997196 hasConcept C504460877 @default.
- W4247997196 hasConcept C71924100 @default.
- W4247997196 hasConcept C98274493 @default.
- W4247997196 hasConceptScore W4247997196C10146269 @default.
- W4247997196 hasConceptScore W4247997196C112705442 @default.
- W4247997196 hasConceptScore W4247997196C126322002 @default.
- W4247997196 hasConceptScore W4247997196C185592680 @default.
- W4247997196 hasConceptScore W4247997196C42404028 @default.
- W4247997196 hasConceptScore W4247997196C43617362 @default.
- W4247997196 hasConceptScore W4247997196C44249647 @default.
- W4247997196 hasConceptScore W4247997196C504460877 @default.
- W4247997196 hasConceptScore W4247997196C71924100 @default.
- W4247997196 hasConceptScore W4247997196C98274493 @default.
- W4247997196 hasIssue "1" @default.
- W4247997196 hasLocation W42479971961 @default.
- W4247997196 hasLocation W42479971962 @default.
- W4247997196 hasLocation W42479971963 @default.
- W4247997196 hasLocation W42479971964 @default.
- W4247997196 hasOpenAccess W4247997196 @default.
- W4247997196 hasPrimaryLocation W42479971961 @default.
- W4247997196 hasRelatedWork W1977636014 @default.
- W4247997196 hasRelatedWork W1986974242 @default.
- W4247997196 hasRelatedWork W2127903072 @default.
- W4247997196 hasRelatedWork W2184652695 @default.
- W4247997196 hasRelatedWork W2415374863 @default.
- W4247997196 hasRelatedWork W2792233399 @default.
- W4247997196 hasRelatedWork W2973103339 @default.
- W4247997196 hasRelatedWork W3089081291 @default.
- W4247997196 hasRelatedWork W3145656073 @default.
- W4247997196 hasRelatedWork W76620371 @default.
- W4247997196 hasVolume "15" @default.
- W4247997196 isParatext "false" @default.
- W4247997196 isRetracted "false" @default.
- W4247997196 workType "article" @default.